The DNA mismatch repair (MMR) system guards against genomic instability, therefore the mutations in the human MMR genes cause the majority of the hereditary nonpolyposis colorectal cancer (HNPCC) and a small percentage of the sporadic colon cancer. hMSH2 is one of MMR genes involved in the correction of mispairing during replication and its mutations are associated with both -microsatellite instability and the hereditary and sporadic colon tumourgenesis. The aim of this study was to analyse the T/G mutation (codon 458) in exon 8 of hMSH2 gene in the sporadic colon cancer cells. We also examined the relationship between the T/G mutation of hMSH2 gene, and the selected prognostic factors such as Dukes' stage, histolo-gical grade and lymph node metastasis. We analysed samples of tumour from 75 patients with sporadic colorectal cancers. The mutation in the hMSH2 gene wa-re determined by the RFLP-PCR. We found T/G mutation in exon 8 of hMSH2 gene in 5 patients (6,7%). There was no statistically significant difference between this mutation and selected clinical parameters. The results of our studies revealed that mutations of hMSH2 gene may lead to development of colorectal cancer. No dependence between the mutation of hMSH2 gene and clinical parameters, suggests that the mutation of hMSH2 gene may have a critical significa-nce for the first steps of carcinogenesis in colon epithelial.
INTRODUCTION

C
olorectal cancer is the second most common cause of cancer death in the Poland accounting for 23,8 /male/ and 20,7 /female/ for 100 000 deaths per year. The overall five-year survival rate is estimated at 20% 1, 2 . Colorectal cancer can progress through two pathways of genomic instability. The first more common chromosomal instability with frequent cytogenetic abnormalities and allelic losses is associated with inactivation of tumor supressor genes such as APC, p53, DCC, SMAD2 and SMAD4 3, 4 . A second microsatellite instability (MSI) which is characterized by the accumulation of somatic alteration in the length of simple, repeated sequences -microsatellites 5, 6 . Colorectal cancers with MSI display allelic losses at tumour suppressor loci infrequent, instead these tumors accumulate mutation in microsatelite in coding region of specific genes that are implicated in tumour progression, such as TGFRII, IGFIIR, hMSH3, hMSH6, and BAX
7
. The MSI have been observed in tumours from patients with the hereditary nonpolyposis colorectal cancer (HNPCC) as well as a significant proportion of the sporadic colon cancer 8 . The MSI phenotypes found in tumour from patients with HNPCC results from defect in the DNA mismatch repair (MMR) system, which serves to correct replication errors such as misincorporated bases, nucleotide insertions and deletions. This defect in MMR system are caused by germ-line mutation of the MMR genes, the most common being hMLH1 or hMSH2, this two genes, as well as hMSH3, hMSH6 and hPMS2 all participated in DNA mismatch repair 9, 10 . Recent studies indicated that MMR proteins not only protect mammalian genomes by repairing mismatched bases, but also by mediating DNA damage-induced apoptosis as part of the cellular responses to endogenous and exogenous agents 11, 12 . Although defective MMR is believed to be responsible for the occurrence of the majority of colon tumors in patients with HNPCC, the genetic defects of MMR genes responsible for occurrence of sporadic form this cancer has yet not be clearly delineated. Therefore, the aim of this study was to determined influence of mutation in hMSH2 gene on the occurrence and progression of sporadic colon cancer. We analyzed the T/G mutation (codon 458) in exon 8 of hMSH2 gene in the sporadic colon cancer cells. This mutation was identified in previous study in Swedish HNPCC family and in anther non related HNPCC family consisted of 3 relatives with colon cancer presenting before the age of 50 
METHODS
Determination of the hMSH2 mutation by RFLP-PCR
DNA from deparaffinzed sections of paraffin embedded tumour of sporadic colon cancer isolated by proteinase K digestion and phenol/chloroform extraction. T\G mutation in the 458 codon of hMSH2 gene ware determined by the PCR-based MseI restriction fragment length polymorphism. The following primers were used: 5' TGA GAT CTT TTT ATT TGT TTG TTT T 3' (forward primer) and 5' TTT GCT TTT TAA AAA TAA CTA CTG C 3' (reverse primer) (GDB, http://www.gdb.org). MseI digestion would cleave PCR products deriving from the mutations allele but not those deriving from the wild allele. PCRamplified DNA was digested with 3 U of MseI in a total volume of 18 l. The solution was incubated at 37°C for 16 h. 15 l aliquots of the digest were electrophoresed on a 7% horizontal polyacrylamide gel and visualized by silver staining. (Fig. 1.) 
RESULTS AND DISCUSSION
More recently, carriers of potentially pathogenic mutations in the hMLH1/hMSH2 genes have consistently been shown to be at a greatly increased risk of developing colorectal cancer compared with the general population 14 . In this study we analysed mutation in hMSH2 gene in sporadic colon cancer cells. hMSH2 involved in the correction of mispairing during replication. This protein interacts with hMSH6 or hMSH3 recognizes and binds any errors that may have occurred during DNA replication, and a larger protein complex is then recruited to excise the incorrect daughter sequence and replace it with the correct sequence, using the parental strand as a template 15, 16 . In cell lines that have mutation in hMSH2 or hMLH1 gene develop the mutator phenotype appears to play crucial role in progression of carcinogenesis. However, mutation in other MMR gene than hMSH2 and hMLH2 may induced microsatelite instability in cell but not necessarily an increase in tumour formation. In the process of investigation the role MMR gene in various tumour cell lines were found that hMSH2 and hMLH1 not only repair DNA damage but also induced apoptosis by interaction with PCNA 11, 17 . The T/G substitution in the codon 458 in exon 8 of the hMSH2 gene resulted in an alteration from Leu (TTA) to codon stop. This alteration lead to synthesized truncating hMSH2 protein, without its functional domains responsible for induction of apoptosis (amino acids 116-601) and C-terminal ATPase domain responsible for binding to DNA damage 11, 12 . We found T/G mutation in exon 8 of hMSH2 gene in 5 patients (6,7%). There is no difference in distribution of mutation in hMSH2 gene for different age (Table 1 ) groups or gender ( Table 2 ). The results of our studies revealed that mutation T/G in exon 8 of hMSH2 gene may lead to development of sporadic colorectal cancer because this mutation led to loss of both function of hMSH2 -mismatch repair and induction of apoptosis..
In most studies, patients with MSI colorectal cancer associated with mutation in MMR gene have better prognosis than do those with microsatelite stable carcinoma 18, 19 . We also examined the relationship between the T/G mutation of hMSH2 gene, and the selected prognostic factors. There was no statistically significant difference between frequencies of T/G mutation of the hMSH2 gene and selected clinical parameters such as Dukes' stage (Table 3) , histological grade (Table 4) , lymph node metastasis (Table 5). No dependence between the mutation of hMSH2 gene and clinical parameters such as degree of malignancy, progression of cancer according to Dukes' classification, presence and localization of lymph nodes metastases, suggests that the mutation of hMSH2 gene may have a critical significance for the first steps of carcinogenesis in colon epithelial. 
